Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 46, 2011 - Issue 4
Submit an article Journal homepage
347
Views
40
CrossRef citations to date
0
Altmetric
Gastrointestinal Cancer

Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids

Constantin S. Jianu Department of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, NorwayCorrespondence[email protected]
,
Reidar Fossmark Department of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
,
Unni Syversen Department of Endocrinology, St. Olavs Hospital, Trondheim, Norway; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
,
Øyvind Hauso Department of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
,
Vidar Fykse Department of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway
&
Helge L. Waldum Department of Gastroenterology and Hepatology, St. Olavs Hospital, Trondheim, Norway; Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway
Pages 456-463 | Received 09 Sep 2010, Accepted 07 Nov 2010, Published online: 07 Dec 2010

Citations (40)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Daniel H Kwon, Eric K Nakakura, Emily K Bergsland & Sun-Chuan Dai. (2017) Gastric neuroendocrine tumors: management and challenges. Gastrointestinal Cancer: Targets and Therapy 7, pages 31-37.
Read now
Liv Sagatun, Reidar Fossmark, Constantin S. Jianu, Gunnar Qvigstad, Ivar S. Nordrum, Patricia Mjønes & Helge L. Waldum. (2016) Follow-up of patients with ECL cell-derived tumours. Scandinavian Journal of Gastroenterology 51:11, pages 1398-1405.
Read now
Ben Lawrence, Malcolm Anderson, Simon Schimmack, Michael Findlay, Mark Kidd & Irvin Modlin. (2013) Neoplastic lesions of endocrine cells in the gastrointestinal tract: ten evolving principles as a basis for clinical understanding. Gastrointestinal Cancer: Targets and Therapy 3, pages 1-17.
Read now
Kristian Bjøro. (2011) This Month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:4, pages 387-388.
Read now

Articles from other publishers (36)

Fernando Sebastian-Valles, Blanca Bernaldo Madrid, Carolina Sager, Elena Carrillo López, Sara Mera Carreiro, Laura Ávila Antón, Noelia Sánchez-Maroto García, Miguel Antonio Sampedro-Nuñez, Jose Ángel Díaz Pérez & Mónica Marazuela. (2023) Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors. Biomedicines 11:3, pages 872.
Crossref
Conrad J. Fernandes, Galen Leung, Jennifer R. Eads & Bryson W. Katona. (2022) Gastroenteropancreatic Neuroendocrine Tumors. Gastroenterology Clinics of North America 51:3, pages 625-647.
Crossref
Ziqi Yu, Aiyao Wang, Chong Hu, Tao Yu & Jianyong Chen. (2022) Type-1 Grade 2 Multi-Focal Gastric Neuroendocrine Tumors Secondary to Chronic Autoimmune Gastritis. Frontiers in Medicine 9.
Crossref
Hüseyin Köseoğlu, Tolga Duzenli & Mesut Sezikli. (2021) Gastric neuroendocrine neoplasms: A review. World Journal of Clinical Cases 9:27, pages 7973-7985.
Crossref
Helge Waldum. (2021) Tumor Classification Should Be Based on Biology and Not Consensus: Re-Defining Tumors Based on Biology May Accelerate Progress, An Experience of Gastric Cancer. Cancers 13:13, pages 3159.
Crossref
Davide Ravizza & Giancarla Fiori. 2021. Neuroendocrine Neoplasia Management. Neuroendocrine Neoplasia Management 179 190 .
Gabriel Antonio Roberto, Carolina Magalhães Britto Rodrigues, Renata D’Alpino Peixoto & Riad Naim Younes. (2020) Gastric neuroendocrine tumor: A practical literature review. World Journal of Gastrointestinal Oncology 12:8, pages 850-856.
Crossref
Klaire Exarchou, Nathan Howes & David Mark Pritchard. (2020) Systematic review: management of localised low‐grade upper gastrointestinal neuroendocrine tumours. Alimentary Pharmacology & Therapeutics 51:12, pages 1247-1267.
Crossref
Roberta Elisa Rossi, Pietro Invernizzi, Vincenzo Mazzaferro & Sara Massironi. (2020) Response and relapse rates after treatment with long‐acting somatostatin analogs in multifocal or recurrent type‐1 gastric carcinoids: A systematic review and meta‐analysis. United European Gastroenterology Journal 8:2, pages 140-147.
Crossref
Katie A. Lloyd, Bryony N. Parsons, Michael D. Burkitt, Andrew R. Moore, Stamatia Papoutsopoulou, Malcolm Boyce, Carrie A. Duckworth, Klaire Exarchou, Nathan Howes, Lucille Rainbow, Yongxiang Fang, Claus Oxvig, Steven Dodd, Andrea Varro, Neil Hall & D. Mark Pritchard. (2020) Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors. Cellular and Molecular Gastroenterology and Hepatology 10:1, pages 113-132.
Crossref
Helge L. Waldum, Øystein F. Sørdal & Patricia G. Mjønes. (2019) The Enterochromaffin-like [ECL] Cell—Central in Gastric Physiology and Pathology. International Journal of Molecular Sciences 20:10, pages 2444.
Crossref
A. V. Alekberzade, N. N. Krylov, E. M. Lipnitskiy, R. O. Shakhbazov & F. Azari. (2019) Gastric neuroendocrine tumors. Khirurgiya. Zhurnal im. N.I. Pirogova:12, pages 111.
Crossref
Marina Tsoli, Eleftherios Chatzellis, Anna Koumarianou, Dionysia Kolomodi & Gregory Kaltsas. (2018) Current best practice in the management of neuroendocrine tumors. Therapeutic Advances in Endocrinology and Metabolism 10, pages 204201881880469.
Crossref
Asim Shabbir, Jimmy So & Hrishikesh Salgaonkar. 2018. Evidence-Based Endocrine Surgery. Evidence-Based Endocrine Surgery 455 465 .
Massimo Carlini, Daniela Apa, Domenico Spoletini, Michele Grieco, Marialuisa Appetecchia, Francesca Rota, Salvatore Palazzo & Salvatore Turano. 2018. Abdominal Neuroendocrine Tumors. Abdominal Neuroendocrine Tumors 139 152 .
Davide Campana, Nico Pagano, Nicole Brighi, Dario Fabbri, Maria Rinzivillo, Gianfranco Delle Fave, Guido Biasco & Francesco Panzuto. 2018. Neuroendocrine Tumors in Real Life. Neuroendocrine Tumors in Real Life 219 234 .
Jun Liong Chin & Dermot O’Toole. (2017) Diagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors. Clinical Endoscopy 50:6, pages 520-529.
Crossref
G. Cadiot, H. Brixi, A. Marchal & M. -D. Diebold. (2016) Comment prendre en charge les tumeurs carcinoïdes gastriques ?How to manage gastric carcinoid tumors?. Acta Endoscopica 46:3, pages 196-199.
Crossref
Yuichi Sato, Satoru Hashimoto, Ken-ichi Mizuno, Manabu Takeuchi & Shuji Terai. (2016) Management of gastric and duodenal neuroendocrine tumors. World Journal of Gastroenterology 22:30, pages 6817.
Crossref
G. Delle Fave, D. O''Toole, A. Sundin, B. Taal, P. Ferolla, J.K. Ramage, D. Ferone, T. Ito, W. Weber, Z. Zheng-Pei, W.W. De Herder, A. Pascher & P. Ruszniewski. (2016) ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. Neuroendocrinology 103:2, pages 119-124.
Crossref
Sara Massironi, Alessandra Zilli, Ilaria Fanetti, Clorinda Ciafardini, Dario Conte & Maddalena Peracchi. (2015) Intermittent treatment of recurrent type-1 gastric carcinoids with somatostatin analogues in patients with chronic autoimmune atrophic gastritis. Digestive and Liver Disease 47:11, pages 978-983.
Crossref
Sara Massironi, Alessandra Zilli & Dario Conte. (2015) Somatostatin analogs for gastric carcinoids: For many, but not all. World Journal of Gastroenterology 21:22, pages 6785-6793.
Crossref
Kali Zhou & Wendy Ho. 2015. Management of Pancreatic Neuroendocrine Tumors. Management of Pancreatic Neuroendocrine Tumors 83 93 .
Yuichi Sato. (2014) Clinical features and management of type I gastric carcinoids. Clinical Journal of Gastroenterology 7:5, pages 381-386.
Crossref
Gregory Kaltsas, Simona Grozinsky-Glasberg, Krystallenia I. Alexandraki, Dimitrios Thomas, Apostolos V. Tsolakis, David Gross & Ashley B. Grossman. (2014) Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms. Clinical Endocrinology 81:2, pages 157-168.
Crossref
Aksel Foss & Jan P. Lerut. (2014) Liver transplantation for metastatic liver malignancies. Current Opinion in Organ Transplantation 19:3, pages 235-244.
Crossref
Sapna Rustagi, Jonathan Yao, Richard R.P. Warner & Celia M. Divino. (2013) Laparoscopic Antrectomy for Retained Antrum in Type 1 Gastric Carcinoid. Pancreas 42:6, pages 1040-1042.
Crossref
Mark Kidd, Bjorn Gustafsson & Irvin M. Modlin. (2013) Gastric Carcinoids (Neuroendocrine Neoplasms). Gastroenterology Clinics of North America 42:2, pages 381-397.
Crossref
Senthil V. Murugesan, Islay A. Steele, Rod Dimaline, Graeme J. Poston, Milind Shrotri, Fiona Campbell, Andrea Varro & D. Mark Pritchard. (2013) Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours. European Journal of Gastroenterology & Hepatology 25:4, pages 474-481.
Crossref
Christos Toumpanakis & Martyn E. Caplin. (2013) Update on the Role of Somatostatin Analogs for the Treatment of Patients With Gastroenteropancreatic Neuroendocrine Tumors. Seminars in Oncology 40:1, pages 56-68.
Crossref
Marianne Pavel, Mark Kidd & Irvin Modlin. (2013) Systemic Therapeutic Options for Carcinoid. Seminars in Oncology 40:1, pages 84-99.
Crossref
R. Fossmark, Ø. Sørdal, C. S. Jianu, G. Qvigstad, I. S. Nordrum, M. Boyce & H. L. Waldum. (2012) Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A. Alimentary Pharmacology & Therapeutics 36:11-12, pages 1067-1075.
Crossref
Dermot O'Toole, Gianfranco Delle Fave & Robert T. Jensen. (2012) Gastric and duodenal neuroendocrine tumours. Best Practice & Research Clinical Gastroenterology 26:6, pages 719-735.
Crossref
Mark Kidd & Bjorn I. Gustafsson. (2012) Management of Gastric Carcinoids (Neuroendocrine Neoplasms). Current Gastroenterology Reports 14:6, pages 467-472.
Crossref
Andrea Frilling, Goran Åkerström, Massimo Falconi, Marianne Pavel, Jose Ramos, Mark Kidd & Irvin Mark Modlin. (2012) Neuroendocrine tumor disease: an evolving landscape. Endocrine-Related Cancer 19:5, pages R163-R185.
Crossref
David A. Crosby, Claire L. Donohoe, Louise Fitzgerald, Cian Muldoon, Brian Hayes, Dermot O’Toole & John V. Reynolds. (2012) Gastric NeuroendocrineTumours. Digestive Surgery 29:4, pages 331-348.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.